FDAsafety guidance66% confidence
Generic Drugs: Questions & Answers
Source: FDA
Why This Matters
Why this matters: provides agency context on safety guidance that may shape timing or evidence expectations for TRAVERE; the same agency is already in play for this signal, so precedent weight is higher.
Regulatory Analysis
A generic drug is a medication created to be the same as an already marketed brand-name drug in dosage form, safety, strength, route of administration, quality, performance characteristics, and intended use.
Supporting Context
- Therapeutic area
- Nephrology · SGLT2 Inhibitor
- Sub-indication
- General
Related signal: FDA Accepts Supplement for FILSPARI (SPARSENTAN) by TRAVERE
Source
FDA document
View source